Recursion Pharmaceuticals, Inc. RXRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s price / sales?
- Recursion Pharmaceuticals, Inc. (RXRX) reported price / sales of 24.4× in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s price / sales changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s price / sales decreased by 31.3% year-over-year, from 35.6× to 24.4×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s price / sales?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s price / sales has grown at a -43.9% compound annual growth rate (CAGR), from 287.3× to 28.5×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.